FDANews
FDAnews Device Daily Bulletin

India Sets Price Controls for Knee Implants

Aug. 24, 2017

Health authorities in India have imposed price caps on orthopedic knee implants.

The price for cobalt chromium implants, used in four-fifths of knee-replacement surgeries in India, will go down 65 percent on average under the new regulations, Indian media reported.

In announcing the caps, the National Pharmaceutical Pricing Agency referred to “unjustified, unreasonable and irrational” markups on the implants, leading to “exorbitant” prices. The agency earlier this summer imposed price caps on cardiac stents.

View today's stories